Dhillon et al. showed that MCF7-CycE, a breast cancer cell line overexpressing cyclin E (which, in turn, binds E2F4), was capable of overriding tamoxifen-mediated growth arrest in comparison to its wild-type MCF7 counterpart [55]. The gene discussed is CCNE1; the disease is breast cancer.